PE20110366A1 - Procedimiento de obtencion de los compuestos opticamente activos (s)-(-)-2-(n-propilamino)-5-metoxitetralina y (s)-(-)-2-(n-propilamino)-5-hidroxitetralina - Google Patents

Procedimiento de obtencion de los compuestos opticamente activos (s)-(-)-2-(n-propilamino)-5-metoxitetralina y (s)-(-)-2-(n-propilamino)-5-hidroxitetralina

Info

Publication number
PE20110366A1
PE20110366A1 PE2011000650A PE2011000650A PE20110366A1 PE 20110366 A1 PE20110366 A1 PE 20110366A1 PE 2011000650 A PE2011000650 A PE 2011000650A PE 2011000650 A PE2011000650 A PE 2011000650A PE 20110366 A1 PE20110366 A1 PE 20110366A1
Authority
PE
Peru
Prior art keywords
propylamino
optically active
procedure
compounds
metoxythethraline
Prior art date
Application number
PE2011000650A
Other languages
English (en)
Inventor
Olondriz Francisco Marquillas
Marco Marta Pomares
Original Assignee
Interquim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41728366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20110366(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Interquim Sa filed Critical Interquim Sa
Publication of PE20110366A1 publication Critical patent/PE20110366A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

REFERIDA A UN PROCEDIMIENTO PARA LA OBTENCION DE LOS COMPUESTOS, OPTICAMENTE ACTIVOS, (S)-(-)-2-(N-PROPILAMINO)-5-METOXITETRALINA [S-(II)] Y (S)-(-)-2-(N-PROPILAMINO)-5-HIDROXITETRALINA [S-(III)], QUE COMPRENDE LA RESOLUCION OPTICA DE LOS COMPUESTOS (II) Y (III) CON UNA FORMA OPTICAMENTE ACTIVA DE LA N-(3,5-DINITROBENZOIL)-ALFA-FENILGLICINA. TAMBIEN ESTA REFERIDA A LAS SALES FORMADAS ENTRE LOS COMPUESTOS DE FORMULAS S-(II) Y S-(III) CON EL ACIDO (+)-N-(3,5-DINITROBENZOIL)-ALFA-FENILGLICINA Y (-)-N-(3,5-DINITROBENZOIL)-ALFA-FENILGLICINA, RESPECTIVAMENTE. DICHOS COMPUESTOS Y SALES SON UTILES COMO INTERMEDIARIOS EN LA OBTENCION DEL (6S)-(-)-5,6,7,8-TETRAHIDRO-6-[PROPIL-(2-TIENIL)ETIL]AMINO-1-NAFTOL (ROTIGOTINA)
PE2011000650A 2008-10-13 2009-10-09 Procedimiento de obtencion de los compuestos opticamente activos (s)-(-)-2-(n-propilamino)-5-metoxitetralina y (s)-(-)-2-(n-propilamino)-5-hidroxitetralina PE20110366A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200802890 2008-10-13

Publications (1)

Publication Number Publication Date
PE20110366A1 true PE20110366A1 (es) 2011-06-20

Family

ID=41728366

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011000650A PE20110366A1 (es) 2008-10-13 2009-10-09 Procedimiento de obtencion de los compuestos opticamente activos (s)-(-)-2-(n-propilamino)-5-metoxitetralina y (s)-(-)-2-(n-propilamino)-5-hidroxitetralina

Country Status (16)

Country Link
US (1) US8604242B2 (es)
EP (1) EP2346811B1 (es)
JP (1) JP5595404B2 (es)
KR (1) KR101624760B1 (es)
CN (1) CN102143937B (es)
AU (1) AU2009305477B2 (es)
BR (1) BRPI0920645A2 (es)
CA (1) CA2735101C (es)
CL (1) CL2011000830A1 (es)
ES (1) ES2396066T3 (es)
HK (1) HK1160106A1 (es)
IL (1) IL211791A (es)
MX (1) MX2011003930A (es)
PE (1) PE20110366A1 (es)
RU (1) RU2473538C2 (es)
WO (1) WO2010043571A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009305477B2 (en) 2008-10-13 2014-04-17 Interquim, S.A. Process for the preparation of optically active (S)-(-)-2- (N-propylamino)-5-methoxytetraline and (S)-(-)-2- (N-propylamino)-5-hydroxytetraline compounds
KR20130122721A (ko) 2010-06-25 2013-11-08 유씨비 파르마 게엠베하 질소 치환된 （ｓ）―５―알콕시―２―아미노테트랄린 유도체의 분리 방법
CN102070470A (zh) * 2010-11-05 2011-05-25 天津药物研究院 制备s(-)2-(n-正丙基)胺基-5-甲氧基四氢萘的方法
BR112013033559A2 (pt) * 2011-06-27 2016-08-16 Shan Dong Luye Pharm Co Ltd método para industrialmente preparar amino-5,6,7,8-tetra-hidronaftol substituído de nitrogênio
EP2816030A1 (en) * 2013-06-20 2014-12-24 Duke Chem, S. A. Process for the preparation of frovatriptan and its enantiomer
CN113234057B (zh) * 2021-06-03 2022-12-02 成都工业学院 一种罗替戈汀的制备方法
CN114805095B (zh) * 2022-05-11 2023-07-21 上海柏狮生物科技有限公司 一种(s)-5-甲氧基-1,2,3,4-四氢-n-丙基-2-萘胺的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
US4564628A (en) 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
US4657925A (en) 1984-08-13 1987-04-14 Nelson Research & Development Co. Method and compositions for reducing the intraocular pressure of mammals
US4584828A (en) * 1984-05-07 1986-04-29 Bentley Robert J Brush rake
US4885308A (en) 1984-08-13 1989-12-05 Nelson Research & Development Co. Method and compositions for treatment of parkinsonism syndrome in mammals
AU5439890A (en) * 1989-05-09 1990-11-29 Whitby Research, Inc. A method of reducing body weight and food intake using a dopamine d2 receptor agonist
US5234945A (en) 1989-05-09 1993-08-10 Whitby Research, Inc. Method of producing body weight and food intake using a dopamine D2 receptor agonist
ATE172712T1 (de) * 1989-05-31 1998-11-15 Upjohn Co Zns-wirksame 8-heterocyclyl-2-aminotetralin derivate
US4968837A (en) 1989-07-28 1990-11-06 Ethyl Corporation Resolution of racemic mixtures
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
US5442117A (en) * 1993-12-13 1995-08-15 Albemarle Corporation Enantiomeric resolution
JP2002265460A (ja) * 2000-12-28 2002-09-18 Takeda Chem Ind Ltd 光学活性２，３−ジヒドロベンゾフラン化合物の製造法
DE60136566D1 (de) 2000-12-28 2008-12-24 Takeda Pharmaceutical Verfahren zur herstellung von optisch aktiven 2,4-dihydrobenzofuranverbindungen
ES2200699B1 (es) * 2002-07-12 2005-10-01 Ragactives, S.L Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.
DE10359528A1 (de) 2003-12-18 2005-07-28 Schwarz Pharma Ag (S)-2-N-Propylamino-5-hydroxytetralin als D3-agonistisches Therapeutikum
DE10361258A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
AU2009305477B2 (en) 2008-10-13 2014-04-17 Interquim, S.A. Process for the preparation of optically active (S)-(-)-2- (N-propylamino)-5-methoxytetraline and (S)-(-)-2- (N-propylamino)-5-hydroxytetraline compounds

Also Published As

Publication number Publication date
KR101624760B1 (ko) 2016-05-26
AU2009305477B2 (en) 2014-04-17
CN102143937B (zh) 2014-07-02
CA2735101A1 (en) 2010-04-22
RU2473538C2 (ru) 2013-01-27
US20110152543A1 (en) 2011-06-23
RU2011119224A (ru) 2012-11-20
HK1160106A1 (en) 2012-08-10
BRPI0920645A2 (pt) 2016-01-12
MX2011003930A (es) 2011-05-03
CA2735101C (en) 2015-09-29
EP2346811B1 (en) 2012-08-15
CL2011000830A1 (es) 2012-03-30
CN102143937A (zh) 2011-08-03
WO2010043571A1 (en) 2010-04-22
IL211791A (en) 2014-06-30
ES2396066T3 (es) 2013-02-19
EP2346811A1 (en) 2011-07-27
AU2009305477A1 (en) 2010-04-22
JP5595404B2 (ja) 2014-09-24
JP2012505183A (ja) 2012-03-01
KR20110069036A (ko) 2011-06-22
IL211791A0 (en) 2011-06-30
US8604242B2 (en) 2013-12-10

Similar Documents

Publication Publication Date Title
PE20110366A1 (es) Procedimiento de obtencion de los compuestos opticamente activos (s)-(-)-2-(n-propilamino)-5-metoxitetralina y (s)-(-)-2-(n-propilamino)-5-hidroxitetralina
CR20110134A (es) Compuestos con anillos espiro-tricíclicos como moduladores de Beta-secretasas y métodos de uso
CO6561771A2 (es) Nuevos compuestos triciclicos
CR20160007A (es) Nuevos compuestos triciclicos
ECSP11011079A (es) Nuevos compuestos de hidroxiareno.
CR20110135A (es) INHIBIDORES DE cMET
AR080898A1 (es) Lentes de contacto fotosensibles solo para pupila que muestran una visualizacion optica deseable y comodidad
HN2007000267A (es) Compuestos de 4-metil piridopirimidinoma
DOP2010000148A (es) Derivados bis-(sulfonilzmino) en terapia 066
CO6541606A2 (es) Espiroindolinona- pirrolidinas
BR112012007828A2 (pt) compostos, processo para preparar os compostos, e, composição farmacêutica.
BR112012029003A2 (pt) lente de menisco líquido arqueada
AR079516A1 (es) Modelo de ojo para lentes de contacto
BR112013007873A2 (pt) lentes de menisco líquido incluindo zonas de tensão variáveis
CO6511272A2 (es) Compustos de pirazol como antahonistas de crth2
CO7141413A2 (es) Proceso para la preparación de derivados de 2-(1-hidroxi-alquil)-cromen-4-ona ópticamente puros y opcionalmente sustituidos y su uso en la preparación de compuestos farmacéuticos
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
ECSP11010816A (es) Nuevos Compuestos
CR11680A (es) Inhibidores de Desacetilasas B a Base de Hidroxamato
CR20110219A (es) Ácidos naftilacéticos
UY33176A (es) Derivados de oxazolopirimidina sustituida en 2, 5, 7.
CR20120311A (es) Derivados de sulfonamida heterocíclicos
CU20110108A7 (es) [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos
DOP2011000053A (es) Agentes antifungicos
CL2011001829A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal